InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Kowalsky Matthew Paul. Officer active across 2 companies, notably Sigilon Therapeutics, Inc.. Aggregated, 2 reports have been recorded. History available since 12 February 2026. The latest transaction was disclosed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations